Gingko Pu'er raw tea and preparation method thereof

Abstract

The invention discloses a ginkgo Pu'er raw tea and a preparation method thereof. The ginkgo Pu'er raw tea is composed of 45-65% of ginkgo leaves and 35-55% of Pu'er raw tea. Through the processing process carried out on the ginkgo leaves, active ingredients of the ginkgo leaves are activated and differentiated, and the active ingredients of the ginkgo leaves can be rapidly leached when the ginkgoPu'er raw tea is brewed, thus effects of beneficial ingredients of the ginkgo leaves are improved and guaranteed. The ginkgo Pu'er raw tea disclosed by the invention has good taste and strong fragrance, undesirable bitter and acerbic senses of common ginkgo Pu'er raw tea are changed, people can obtain health care effect while enjoying the tea, beneficial effects of the prepared ginkgo Pu'er raw tea, tea bags and block tea can be guaranteed, and the preparation method is simple, is easy to operate and can be accepted by the masses easily. The ginkgo Pu'er raw tea disclosed by the invention is a novel health care tea used for preventing and treating cerebral vascular and cardiovascular arteriosclerosis, hypertension and senile dementia and has the effects of diuresis, digestion aid, dispelling the effects of alcohol, losing weight, enhancing appetite, dispelling wind and relieving exterior syndrome as well as clearing head and eyes.

Description

technical field [0001] The invention relates to the technical field of health drinks, in particular to a raw ginkgo Pu'er tea and a preparation method thereof. technical background [0002] The medical and health care value of Ginkgo biloba has been revealed by scholars at home and abroad. Ginkgo biloba contains more than 20 kinds of flavonoids, the content of which is more than 24% in the total extract, mainly including Ginkgo diketone (Cinkgetin), Isoginkgo biflavonoids (So ginkgetin), bilobetin. Ginkgo biloba also contains terpene lactone compounds. The diterpene lactones mainly include Ginkgolide A, B, C, M, J, etc., and the sesquiterpene lactone is Bilobalide. In addition, it also contains phenols, 25 beneficial elements, 17 amino acids, alkaloids, etc. Modern research has the functions of improving cardiovascular and cerebrovascular function, relieving asthma, dilating coronary arteries, resisting myocardial ischemia, dilating blood vessels, reducing blood pressure, ...

AI Technical Summary

Problems solved by technology

[0015] In the prior art, health teas prepared from a single ginkgo tea or a combination of ginkgo leaves and tea leaves, or a combination of ginkgo leaves and other beneficial raw materials generally ignore the utilization effect of the active ingredients of ginkgo leaves, resulting in poor product effects. It is difficult to achieve the expected effect, which affects the awareness of consumers and is difficult to promote

The reason is that the cell wall and cell membrane of Ginkgo biloba are constantly lignified during the growth period, and the texture of Ginkgo biloba varies greatly due to different picking time. The main components of Ginkgo biloba are ginkgo ketone compounds, lactone compounds, Organic ingredients such as polyisoamyl alcohol and ginkgo polysaccharides, after being made into tea, simply soaked in boiling water, it is difficult to extract their fat-soluble active ingredients, which is the main reason for the unsatisfactory effect after drinking

The 2nd, existing processing technology is unreasonable, only is simple tea-making method, is difficult to reach the medical curative effect of ginkgo leaf, can not realize the medical value of existing ginkgo tea

[0016] As the cardiovascular and cerebrovascular health problems of middle-aged and elderly people are getting more and more attention, improving the health value of ginkgo biloba and combining the excellent characteristics of raw Pu'er tea should be able to better solve the above problems, especially for people with "three highs" The crowd of people, can bring into play special health-care effect, but there is no relevant report yet in the prior art